Muscle Damage And Calcium Release: What's The Link?

does muscle damage cause calcium release

Calcium is an essential element that plays a crucial role in skeletal muscle function. Skeletal muscle damage can lead to a loss of muscle function, and in severe cases, widespread muscle damage can have significant systemic consequences due to the leakage of intracellular components into the circulation. Contraction-induced muscle damage can result in a loss of calcium homeostasis, leading to elevated intracellular calcium concentrations. This increase in intracellular calcium can trigger calcium-dependent processes such as calpain activation, contributing to further muscle damage. Understanding the role of calcium in muscle damage is essential for developing interventions to mitigate or prevent muscle damage and its associated complications.

Characteristics Values
Muscle damage cause Eccentric contractions
Muscle damage result Disruption of normal muscle protein structure
Muscle damage indicators Infiltration of inflammatory cells, increased resting intracellular calcium concentration, muscle enzyme release, muscle soreness, loss of force
Muscle damage prevention CCB administration, calpain inhibitors, PLA2 inhibitors, ROS scavengers
Muscle function Contraction and relaxation for body movement and posture maintenance
Muscle contraction Caused by calcium release from the sarcoplasmic reticulum
Calcium role Signalling molecule, second messenger
Calcium control Preventing calcium overload, maintaining calcium homeostasis

cyvigor

Eccentric contractions cause muscle damage and increased intracellular calcium concentration

Eccentric contractions are a type of muscle contraction that can cause damage to skeletal muscle, resulting in a disruption of the normal muscle protein structure. This damage is characterised by various metabolic events, including infiltration of inflammatory cells, increased resting intracellular calcium concentration, muscle enzyme release, muscle soreness, and a loss of both voluntary and involuntary force.

Intracellular calcium concentration refers to the amount of calcium ions ([Ca2+]i) inside muscle cells. During eccentric contractions, the accumulation of [Ca2+]i is associated with muscle damage. Specifically, transient Ca2+ accumulation in the cytosol leads to a loss of force production, while continuous high levels of [Ca2+]i, especially following eccentric contractions, result in muscle damage, including disrupted sarcomeres and membranes.

Following eccentric contraction-induced damage, there is a loss of calcium homeostasis, resulting in a sustained elevation of intracellular Ca2+ ([Ca2+]i). This elevation is more rapid and greater in magnitude compared to isometric contractions. Stretch-activated channels (SAC) are largely responsible for this increase in [Ca2+]i during eccentric contractions.

Calcium channel blockers (CCB) have been shown to attenuate the damage-induced rise in intracellular calcium concentration and reduce indices of damage. In one study, healthy males who were treated with CCB showed reduced damage to some sarcomeric proteins, indicating that CCB administration can selectively attenuate muscle damage.

In summary, eccentric contractions cause muscle damage and increased intracellular calcium concentration. The accumulation of [Ca2+]i during eccentric contractions contributes to muscle damage, and CCB administration can help mitigate this damage by reducing the rise in intracellular calcium concentration.

Meth's Impact: Weak Muscles in Babies

You may want to see also

cyvigor

Calcium channel blockers can prevent calcium-induced muscle damage

Calcium is an essential mineral for the human body, and it plays a crucial role in muscle function. Skeletal muscles, in particular, rely on calcium as their main regulatory and signalling molecule. Calcium ions (Ca2+) are involved in the contraction and relaxation of muscles, and they are necessary for muscle plasticity and adaptability.

However, an imbalance in calcium levels can lead to muscle damage. For instance, eccentric contractions can cause damage to skeletal muscles, resulting in a disruption of the normal muscle protein structure. This damage is characterised by increased intracellular calcium concentrations, infiltration of inflammatory cells, muscle enzyme release, muscle soreness, and a loss of force production.

Calcium channel blockers (CCBs) are medications that can help prevent calcium-induced muscle damage. CCBs work by limiting the entry of calcium into cells, slowing down how quickly cells can take in calcium. This reduction in calcium influx can help mitigate the damage caused by elevated intracellular calcium levels. In the context of muscle damage, CCBs have been shown to attenuate damage to some sarcomeric proteins and reduce extreme Z-band streaming, indicating a potential protective effect on muscle structure and function.

Additionally, CCBs can prevent the activation of calcium-dependent neutral proteases (calpains) that contribute to muscle degradation. By blocking calcium channels, CCBs can reduce intracellular calcium concentrations, thereby inhibiting calpain activity and protecting the muscle from further damage.

While CCBs have been shown to be effective in preventing and treating calcium-induced muscle damage, they are more commonly prescribed for conditions related to the heart and blood vessels, such as high blood pressure and arrhythmias. CCBs that target blood vessels help relax the vessels, reducing blood pressure. On the other hand, CCBs targeting heart muscles can help treat heart rhythm problems.

cyvigor

Calcium-activated calpain mechanisms cause muscle damage

Calcium is an essential ion for muscle function, plasticity, and disease. Skeletal muscle, in particular, exhibits high plasticity and uses Ca2+ as its main regulatory and signalling molecule.

Calcium-activated calpain mechanisms have been shown to cause muscle damage. Calpains are a class of proteins that belong to the calcium-dependent, non-lysosomal cysteine proteases. There are three major types of calpains expressed in skeletal muscle: µ-calpain, m-calpain, and calpain 3. They are all Ca2+-dependent proteases, but µ-calpain and m-calpain are calcium-activated proteases and require specific concentrations of Ca2+ for their activation. Calpain 3, on the other hand, requires very little or no Ca2+ for its activation.

Calcium-activated calpain mechanisms play a pivotal role in skeletal muscle damage and wasting, especially after severe burn injuries. Burn injuries cause ER stress, which leads to increased cytoplasmic calcium concentrations in skeletal muscle cells. This calcium overload contributes to initiating calpain activation. Calpains are early mediators in the breakdown of sarcomeric proteins, promoting the release of myofilaments (including actin and myosin) that can then undergo degradation. This degradation of sarcomeric proteins leads to muscle damage, as evidenced by ruptured Z-lines, degraded M-lines, and non-integral myofibrils.

Additionally, contraction-induced muscle damage has been linked to a loss of calcium homeostasis and a subsequent increase in intracellular calcium concentration. This increase in intracellular calcium concentration has been hypothesized to trigger calcium-dependent neutral protease (calpain) activity. In one study, treatment with calcium channel blockers (CCB) attenuated damage to some sarcomeric proteins, indicating that preventing the rise in intracellular calcium concentration can reduce muscle damage.

In summary, calcium-activated calpain mechanisms cause muscle damage, particularly in the context of severe burn injuries and contraction-induced muscle damage. The activation of calpains leads to the breakdown of sarcomeric proteins, resulting in disrupted muscle structure and function.

cyvigor

Calcium is a crucial signalling molecule for muscle function

The role of calcium in muscle function is complex and multifaceted. Calcium is involved in muscle plasticity, muscle development, muscle regeneration, and muscle health. It is also a key factor in muscle excitation-contraction coupling, which is the process by which a muscle fibre generates tension in response to stimulation. Calcium is also involved in the development and contractile function of skeletal muscle.

The ryanodine receptor (RyR) is the major channel for Ca2+ release from intracellular stores in skeletal muscle. It mediates the t-tubular depolarization-induced Ca2+ release from the sarcoplasmic reticulum. The sarcoplasmic reticulum is a critical component of the calcium signalling apparatus, which also includes the troponin protein complex, the Ca2+ pump, and calsequestrin. The troponin protein complex mediates the Ca2+ effect on myofibrillar structures, leading to contraction. The Ca2+ pump is responsible for the reuptake of Ca2+ into the sarcoplasmic reticulum, and calsequestrin is the Ca2+ storage protein in the sarcoplasmic reticulum.

Calcium homeostasis is critical for muscle function. Mitochondria play a significant role in calcium homeostasis by taking up calcium and acting as a calcium buffer. The inositol 1,4,5-trisphosphate receptor (IP3R) is another crucial component of calcium homeostasis in skeletal muscle. IP3Rs are located on the mitochondria-facing surface of the sarcoplasmic reticulum and are critical anchoring sites for ER-mitochondrial contact points. They regulate gene expression, energy metabolism, and mitochondrial function.

Disruption of calcium homeostasis and the resultant sustained elevation of intracellular Ca2+ can lead to muscle damage, including disrupted sarcomeres and membranes. This can be caused by eccentric contractions, which result in increased intracellular calcium concentration. Calcium channel blockers (CCBs) have been shown to be effective in attenuating the damage-induced rise in intracellular calcium concentration and reducing indices of damage.

cyvigor

Intracellular calcium accumulation can lead to muscle damage and regeneration

Calcium is an essential small-molecule biomessenger in skeletal muscle function. It is the main regulatory and signalling molecule used by all muscle fibres. Contraction-induced muscle damage can lead to a loss of calcium homeostasis and a sustained elevation of intracellular calcium levels. This calcium accumulation can cause muscle damage, including disrupted sarcomeres and membranes.

Eccentric contractions cause damage to skeletal muscle, resulting in a disruption of the normal muscle protein structure. This can be characterised by metabolic events such as infiltration of inflammatory cells, increased resting intracellular calcium concentration, muscle enzyme release, muscle soreness, and a loss of force. Subsequent increases in intracellular calcium concentration following the initial contraction-induced injury have been suggested to contribute to the progression of muscle damage.

Calcium channel blockers (CCBs) have been shown to be effective in reducing muscle damage. CCBs can block the entry of calcium via CCB-sensitive calcium channels, preventing the rise in intracellular calcium concentration. This can attenuate damage to some sarcomeric proteins. However, CCB administration does not affect the disruption of dystrophin or α-actinin, muscle CK release, inflammatory cell infiltration, or the contraction-induced force deficit.

Intracellular calcium accumulation can lead to muscle damage, and this damage can trigger muscle regeneration via apoptosis and necrosis. Muscle satellite cells are the major cell type that contributes to muscle repair and regeneration. When muscle is injured, activated muscle satellite cells proliferate and differentiate into skeletal muscle cells, giving rise to new tissue. Calcium dynamics are essential for muscle function, and calcium activity is necessary for the activation and proliferation of muscle satellite cells.

Frequently asked questions

Muscle damage has been linked to a loss of calcium homeostasis, which results in a sustained elevation of intracellular calcium. This calcium accumulation can lead to muscle damage, including disrupted sarcomeres and membranes, and can cause muscle soreness and loss of force.

Calcium acts as a signalling molecule in muscle cells, and its release is governed by an action potential. An increase in intracellular calcium concentration can trigger calcium-dependent protease activity, leading to muscle damage.

Yes, calcium channel blockers (CCBs) have been shown to attenuate muscle damage by preventing the rise in intracellular calcium concentration. This can reduce proteolytic activation and other indices of damage.

Written by
Reviewed by

Explore related products

Share this post
Print
Did this article help you?

Leave a comment